Agonist versus antagonist binding to alpha-adrenergic receptors.
Agonist versus antagonist binding to alpha-adrenergic receptors.
复制标题
与α-肾上腺素能受体结合的激动剂与拮抗剂。
DOI:
10.1073/pnas.77.8.4569
复制
发表时间:
1980
影响因子:
11.1
通讯作者:
Fain,JN
中科院分区:
文献类型:
--
作者:
Hoffman,BB;Michel,T;Kilpatrick,DM;Lefkowitz,RJ;Tolbert,ME;Gilman,H;Fain,JN
The binding properties of two alpha-adrenergic radioligands, [3H]epinephrine (an agonist) and [3H]dihydroergocryptine (an antagonist), were compared in two model systems--membranes derived from human platelets and membranes from rat liver. The platelet contains exclusively alpha 2 and the liver mostly (approximately 80%) alpha 1 receptors. Agonists induce the formation of a guanine nucleotide-sensitive high-affinity state of alpha 2 but not alpha 1 receptors. [3H]Dihydroergocryptine labels all the alpha receptors, whereas [3H]epinephrine at low concentrations labels predominantly the high-affinity form of the alpha 2 receptor in both platelet and liver. However, in the liver, alpha-adrenergic effects such as glycogen phosphorylase activation are shown to be mediated via alpha 1 receptors. Thus, in liver membranes the endogenous "physiological" agonist may not label the physiologically relevant alpha 1 receptors in typical radioligand binding assays using low concentrations of [3H]epinephrine.